Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CREG2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | STT3A | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
mRNA | ABC13-47656900H15.1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.008 |
mRNA | ARL14 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
mRNA | USP11 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
mRNA | CYP2C19 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
mRNA | AQP9 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
mRNA | ULK3 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
mRNA | RGPD1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
mRNA | RSPRY1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |